New Faces of Bladder Cancer Report

The New Faces of Bladder Cancer report captures the real experiences of more than 1,100 people across the United States living with bladder cancer. It offers one of the most comprehensive patient-centered looks at the journey from first symptoms to survivorship – revealing both the progress made in treatment and the gaps that still impact patients every day.

Download the report below to explore key findings on diagnosis delays, mental health support, financial challenges and quality-of-life issues, along with insights that can help clinicians, researchers and advocates improve care for everyone impacted by bladder cancer.

Thank You to Our New Faces of Bladder Cancer Sponsors

In Their Own Words

Hear from New Faces sponsors who supported this important effort:

“The New Faces of Bladder Cancer Survey from BCAN is a breakthrough, giving us the first national, data‑driven view into what patients are truly experiencing and providing context that meaningfully informs the decisions we make in patient care,” said Denise D’Andrea, Senior Director of Medical Affairs Uro-Oncology, Ferring Pharmaceuticals. “Ferring supported this work because it highlights the barriers patients continue to face, and helps clinicians, patient advocates, and industry focus on solutions that matter most.”

“UroGen is proud to sponsor BCAN’s landmark report. These findings reinforce that bladder cancer is often a chronic condition marked by recurrence, repeated procedures, and ongoing uncertainty,” said Mark Schoenberg, M.D., Chief Medical Officer of UroGen. “As patients face years of surveillance and intervention, care decisions must consider long-term quality of life and emotional burden. Elevating the patient voice through data like this is essential to improving care.”

In the Media

Read BCAN’s press release about the New Faces of Bladder Cancer report.